US Patent 7041442 Peptides for vaccinating against human CMV
All edits
Edits on 29 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 20 Nov, 2023
Golden AI
Edits made to:
Infobox (+13 properties)
Article (+445 characters)
Article
Patent abstract
The present invention relates to peptides or peptide derivatives of the 65 kD lower matrix phoshpoprotein of human cytomegalovirus. The peptides disclosed are useful for determining whether subjects have been exposed to human cytomegalovirus. Methods for using these peptides or derivatives thereof to determine the peptide-induced production of interferon-γ and/or TNF-α in CD8+ T cells isolated from subjects are also disclosed.
Infobox
Is a
Patent Jurisdiction
Patent Number
Patent Inventor Names
Elham Khatamzas0
Florian Kern0
Hans-Dieter Volk0
Ingolf-Pascal Surel0
Nicole Faulhaber0
Petra Reinke0
Date of Patent
May 9, 2006
0Patent Application Number
099800580
Date Filed
June 2, 2000
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 7041442 Peptides for vaccinating against human CMV
Find more entities like US Patent 7041442 Peptides for vaccinating against human CMV
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.